116 related articles for article (PubMed ID: 17140048)
1. [Expression of p53 and BCI-2 as prognostic markers and for anatomical location in gastrointestinal stromal tumors (GIST). Clinico-pathological and immunohistochemistry study of 19 cases].
Martínez-Consuegra N; Baquera-Heredia J; de León-Bojorge B; Padilla-Rodríguez A; Hidalgo CO
Rev Gastroenterol Mex; 2006; 71(3):269-78. PubMed ID: 17140048
[TBL] [Abstract][Full Text] [Related]
2. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome.
Feakins RM
Histopathology; 2005 Mar; 46(3):270-9. PubMed ID: 15720412
[TBL] [Abstract][Full Text] [Related]
3. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
7. Study of the expressions of p53 and bcl-2 genes, the telomerase activity and apoptosis in GIST patients.
Wang Q; Kou YW
World J Gastroenterol; 2007 May; 13(18):2626-8. PubMed ID: 17552015
[TBL] [Abstract][Full Text] [Related]
8. Comparing the long-term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database.
Giuliano K; Ejaz A; Reames BN; Choi W; Sham J; Gage M; Johnston FM; Ahuja N
J Surg Oncol; 2018 Sep; 118(3):486-492. PubMed ID: 30129672
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST).
Artigiani Neto R; Logullo AF; Stávale JN; Lourenço LG
Acta Cir Bras; 2012 May; 27(5):315-21. PubMed ID: 22666745
[TBL] [Abstract][Full Text] [Related]
10. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor.
Chen WT; Huang CJ; Wu MT; Yang SF; Su YC; Chai CY
Jpn J Clin Oncol; 2005 Apr; 35(4):207-13. PubMed ID: 15845570
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor.
Liu FY; Qi JP; Xu FL; Wu AP
World J Gastroenterol; 2006 Jul; 12(26):4161-5. PubMed ID: 16830365
[TBL] [Abstract][Full Text] [Related]
13. [Gastrointestinal stromal tumor: a clinicopathological study of 74 cases].
Yang QC; Ji XH; Shen Y; Han F; Zhang XJ; Liu HB
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):6-10. PubMed ID: 15796874
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of gastrointestinal stromal tumor with synchronous carcinoma].
Sun XY; Wu QS; Geng ZH; Li Q; Wang LL; Li XG
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):739-43. PubMed ID: 24447550
[TBL] [Abstract][Full Text] [Related]
15. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
[TBL] [Abstract][Full Text] [Related]
17. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate.
Steinert DM; Oyarzo M; Wang X; Choi H; Thall PF; Medeiros LJ; Raymond AK; Benjamin RS; Zhang W; Trent JC
Cancer; 2006 Apr; 106(7):1617-23. PubMed ID: 16518826
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of prognostic factors in gastrointestinal stromal tumors of the small intestine].
Bai YK; Shao YF; Shi SS; Gao YN; Sun YT; Wan YL
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):213-6. PubMed ID: 16167230
[TBL] [Abstract][Full Text] [Related]
19. [Gastrointestinal stromal tumors of the stomach. Updates and differences compared to other locations].
Wardelmann E; Hohenberger P; Reichardt P; Merkelbach-Bruse S; Schildhaus HU; Büttner R
Pathologe; 2010 May; 31(3):195-8. PubMed ID: 20165949
[TBL] [Abstract][Full Text] [Related]
20. Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: case series of a single institution experience.
Ferreira SS; Werutsky G; Toneto MG; Alves JM; Piantá CD; Breunig RC; Brondani da Rocha A; Grivicich I; Garicochea B
Int J Surg; 2010; 8(4):314-7. PubMed ID: 20380900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
